Post

Moderna most likely met with the previous admins FDA in a regulatory meeting and agreed on that comparator.

Not defending FDA's decision, but this is in the same ACIP MMWR summary and what the decision is based on

yeah thats in the 3rd screenshot above (from the pdf version) it doesn't seem to be a strong rec, and this is from up to date:

I don't get the details. Is this because the gsk did better lobbying, instead of letting true results speak?

Seems like the upshot may be it comes to market anyway, just not in the US and we continue to cede global leadership?

also i would like to have vaccines here for many reasons

This makes it sound promising that we will get it after this administration is gone.